View all newsletters
Receive our newsletter – data, insights and analysis delivered to you

Clinical Trials Industry Pain Points, Jeeva Clinical SaaS solution and Value Propositions

Jeeva Founder and CEO, Dr Harsha Rajasimha shares his personal journey that led him to decide to dedicate his years of postdoctoral research experience at National Institutes of Health (NIH) and US Food and Drug Administration (FDA) to accelerate the development of life-saving therapies for rare and neglected diseases.

Jeeva aims to reduce the patients travel burden in clinical trials by 50% to 80% depending on the trial protocol and participant preferences. By improving the overall user experience for both the research teams and patients, the Jeeva Clinical SaaS solution is sure to cut the development timelines by 20% to 50%.  The modular solution allows the flexibility for a la carte or end-to-end workflow of a hybrid decentralized clinical trial configuration and experience.

Our Jeeva Clinical cloud-based software provides a seamless solution that improves the experience of investigators and patients by decentralizing clinical trials.
When clinical investigators and study coordinators start planning a new study design in the new normal, speed and efficiency are paramount.
Clinical trials are the regulatory mechanisms agencies like the Food and Drug Administration (FDA) use to evaluate and review evidence of safety and efficacy of...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy